Maintenance of bronchodilator response for Advair Diskus 250/50 (fluticasone propionate/salmeterol) but not ipratropium/albuterol in patients with COPD

被引：2
|
作者：
Knobil, K [1 ]
Kalberg, C [1 ]
Merchant, K [1 ]
Emmett, A [1 ]
Cicale, M [1 ]
机构：
[1] GlaxoSmithKline, Raleigh, NC USA
来源：
CHEST | 2004年 / 126卷 / 04期
关键词：
D O I：
10.1378/chest.126.4_MeetingAbstracts.807S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：807S / 807S
页数：1
相关论文
共 50 条
  • [31] The efficacy and safety of fluticasone propionate 500 mg/salmeterol 50 mg combined via diskus®/accuhaler in Chinese patients with Chronic Obstructive Pulmonary Disease (COPD)
    Zheng, Jingping
    Zhong, Nanshari
    Yang, Lan
    Wu, Yarnei
    Chen, Ping
    Wen, Zhongguang
    Huang, Wenjie
    CHEST, 2006, 130 (04) : 182S - 182S
  • [32] COPD-Related Outcomes And Costs For Patients On Combination Fluticasone Propionate/Salmeterol 250/50mcg Versus Anticholinergics In A Comorbid COPD/Depression Population
    Dalal, A. A.
    Shah, M.
    D'Souza, A. O.
    Chaudhari, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [33] Combination of salmeterol/fluticasone propionate via Diskus® improves quality of life in asthma patients.
    Reese, PR
    Mather, DB
    Mahajan, P
    Woodring, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S69 - S69
  • [34] The safety of fluticasone propionate/salmeterol Diskus® in pediatric patients ages 4-11 with asthma
    House, K
    Dorinsky, PM
    Stauffer, J
    Schoaf, L
    Ellsworth, A
    CHEST, 2004, 126 (04) : 911S - 911S
  • [35] The salmeterol/fluticasone propionate combination (50/100mcg) via diskus® has a rapid onset of effect in asthma patients on salmeterol or inhaled corticosteroids
    Nathan, R
    LaForce, C
    Mitchell, D
    Pearlman, D
    Baitinger, L
    Woodring, A
    House, K
    Prillaman, B
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A637 - A637
  • [36] Perception of diskus inhaler for administration of fluticasone propionate and salmeterol: A multicentre study in 703 patients.
    Brambilla, C
    Evano, I
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A630 - A630
  • [37] Survival in COPD patients after regular use of fluticasone propionate and salmeterol
    Soriano, JB
    Vestbo, J
    Pride, NB
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (03) : 560 - 560
  • [38] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
    Jill A Ohar
    Glenn D Crater
    Amanda Emmett
    Thomas J Ferro
    Andrea N Morris
    Ibrahim Raphiou
    Peruvemba S Sriram
    Mark T Dransfield
    Respiratory Research, 15
  • [39] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
    Ohar, Jill A.
    Crater, Glenn D.
    Emmett, Amanda
    Ferro, Thomas J.
    Morris, Andrea N.
    Raphiou, Ibrahim
    Sriram, Peruvemba S.
    Dransfield, Mark T.
    RESPIRATORY RESEARCH, 2014, 15
  • [40] Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus™ inhaler (Seretide™) is effective and safe in children with asthma
    Van den Berg, NJ
    Ossip, MS
    Hederos, CA
    Anttila, H
    Ribeiro, BL
    Davies, PI
    PEDIATRIC PULMONOLOGY, 2000, 30 (02) : 97 - 105
12345